Other RB norms

GF RB 01/2013:20906
GF RB 01/2013:20906
2.9.6. The uniformity of the content of the active substance in the unit dosed drug
GF RB 01/2013:20907
GF RB 01/2013:20907
2.9.7. The strength of the tablets without coating abrasion
GF RB 01/2013:20908
GF RB 01/2013:20908
2.9.8. Compressive strength of tablets
GF RB 01/2013:20909
GF RB 01/2013:20909
2.9.9. Measurement of consistency by penetrometry
GF RB 01/2013:20912
GF RB 01/2013:20912
2.9.12. Sieve analysis
GF RB 01/2013:20914
GF RB 01/2013:20914
2.9.14. Specific surface area
GF RB 01/2013:20916
GF RB 01/2013:20916
2.9.16. Flowability
GF RB 01/2013:20917
GF RB 01/2013:20917
2.9.17. Determination of recoverable parenteral drugs
GF RB 01/2013:20918
GF RB 01/2013:20918
2.9.18. Medications for inhalation: aerodynamic testing of small particles
GF RB 01/2013:20919
GF RB 01/2013:20919
2.9.19. Contamination by mechanical inclusions: invisible particles
GF RB 01/2013:20920
GF RB 01/2013:20920
2.9.20. Contamination by mechanical inclusions: visible particles
GF RB 01/2013:20922
GF RB 01/2013:20922
2.9.22. Determination of softening time of lipophilic suppositories
GF RB 01/2013:20923
GF RB 01/2013:20923
2.9.23. Determination of the density of solid particles using a gas pycnometer
GF RB 01/2013:20926
GF RB 01/2013:20926
2.9.26. Determination of specific surface area by gas adsorption
GF RB 01/2013:20927
GF RB 01/2013:20927
2.9.27. Mass uniformity of a single dose released from a multi-dose container
GF RB 01/2013:20929
GF RB 01/2013:20929
2.9.29. Characteristic dissolution
GF RB 01/2013:20931
GF RB 01/2013:20931
2.9.31. Determination of particle size by laser diffraction
GF RB 01/2013:20932
GF RB 01/2013:20932
2.9.32. Porosity and pore size determination using mercury porosimetry
GF RB 01/2013:20933
GF RB 01/2013:20933
2.9.33. Determination of parameters of crystalline and partially crystalline solids using powder X-ray diffraction
GF RB 01/2013:20934
GF RB 01/2013:20934
2.9.34. Bulk density and density after shrinkage
GF RB 01/2013:20935
GF RB 01/2013:20935
2.9.35. The degree of grinding powders
GF RB 01/2013:20936
GF RB 01/2013:20936
2.9.36. Powder Flow
GF RB 01/2013:20937
GF RB 01/2013:20937
2.9.37. Optical microscopy
GF RB 01/2013:20938
GF RB 01/2013:20938
2.9.38. Determination of particle size by analytical sieving
GF RB 01/2013:20940
GF RB 01/2013:20940
2.9.40. Uniformity of dosage units
GF RB 01/2013:20941
GF RB 01/2013:20941
2.9.41. Abrasion of granules and spheroids
GF RB 01/2013:20942
GF RB 01/2013:20942
2.9.42. Dissolution test for lipophilic solid dosage forms
GF RB 01/2013:20943
GF RB 01/2013:20943
2.9.43. Observed dissolution
GF RB 01/2013:20944
GF RB 01/2013:20944
2.9.44. Medicines for spraying: characteristic
GF RB 01/2013:20945
GF RB 01/2013:20945
2.9.45. Wettability of porous solids, including powders
GF RB 01/2013:2098
GF RB 01/2013:2098
Essential oils
GF RB 01/2013:2371
GF RB 01/2013:2371
Methods for the preparation of homeopathic basic preparations and potentiation
GF RB 01/2013:30100
GF RB 01/2013:30100
3.1. Materials used for the production of containers
GF RB 01/2013:30101
GF RB 01/2013:30101
3.1.1. The materials used for the production of containers for human blood and blood components
GF RB 01/2013:30103
GF RB 01/2013:30103
3.1.3. Polyolefins
GF RB 01/2013:30104
GF RB 01/2013:30104
3.1.4. Polyethylene without additives for containers for parenteral and ophthalmic drugs
GF RB 01/2013:30105
GF RB 01/2013:30105
3.1.5. Polyethylene with additives for containers for parenteral and ophthalmic drugs
GF RB 01/2013:30106
GF RB 01/2013:30106
3.1.6. Polypropylene for containers and closures for parenteral and ophthalmic drugs
GF RB 01/2013:30107
GF RB 01/2013:30107
3.1.7. Polyethylene vinyl acetate for containers and tubes for drugs for parenteral nutrition
GF RB 01/2013:30108
GF RB 01/2013:30108
3.1.8. Silicone oil used as lubricant
GF RB 01/2013:30109
GF RB 01/2013:30109
3.1.9. Silicone elastomer for closures and tubes
GF RB 01/2013:30110
GF RB 01/2013:30110
3.1.10. Materials based on unplasticized polyvinyl chloride for containers for non-injectable aqueous solutions
GF RB 01/2013:30111
GF RB 01/2013:30111
3.1.11. Materials based on unplasticized polyvinyl chloride for containers for solid dosage forms for oral administration
GF RB 01/2013:30113
GF RB 01/2013:30113
3.1.13. Plastic Additives
GF RB 01/2013:30114
GF RB 01/2013:30114
3.1.14. Materials based on plasticized polyvinyl chloride for containers for aqueous solutions for intravenous use
GF RB 01/2013:30115
GF RB 01/2013:30115
3.1.15. Polyethylene terephthalate for non-parenteral drug containers
GF RB 01/2013:30200
GF RB 01/2013:30200
3.2. Containers
GF RB 01/2013:30201
GF RB 01/2013:30201
3.2.1. Pharmaceutical glass containers

All Codes and Regulations

All Categories

Send us a message Expand Collapse

Leave your message in the form below, and we will write back by e-mail!